Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: a nationwide, population-based cohort study

Approximately 30% of patients with clinical stage I non-seminoma (CSI-NS) relapse. Current risk stratification is based on lymphovascular invasion (LVI) alone. The extent to which additional tumor characteristics can improve risk prediction remains unclear.

Source: European Journal of Cancer - March 17, 2024 Category: Cancer & Oncology Authors: Thomas Wagner, Birgitte Gr ønkær Toft, Jakob Lauritsen, Mikkel Bandak, Ib Jarle Christensen, Birte Engvad, Michael Kreiberg, Mads Agerbæk, Lars Dysager, Andreas Carus, Josephine Julie Rosenvilde, Daniel Berney, Gedske Daugaard Tags: Original Research Source Type: research